Analysis by NIH-supported scientists may help identify requirements for HIV vaccine
Bethesda, Maryland–(ENEWSPF)–April 5, 2012. Insights into how the first vaccine ever reported to modestly prevent HIV infection in people might have worked were published online today in the New England Journal of Medicine. Scientists have found that among adults who received the experimental HIV vaccine during the landmark RV144 clinical trial, those who produced relatively high levels of a specific antibody after vaccination…
